Research Article

Investigation of Radiation Interaction Parameters of Anti-Human Immunodeficiency Virus Drugs in Wide Energy Region

Volume: 14 Number: 2 June 27, 2025
EN TR

Investigation of Radiation Interaction Parameters of Anti-Human Immunodeficiency Virus Drugs in Wide Energy Region

Abstract

Human Immunodeficiency Virus (HIV) positive patients are exposed to radiation therapy for the treatment of various types of cancer. During these treatments, it is inevitable that radiation will interact with the antiviral drugs used. Determining the radiation attenuation parameters of drugs used in HIV treatment is therefore considered essential. In this context, the radiation attenuation capabilities of the HIV drugs were analyzed based on the parameters mass attenuation coefficient (MAC), atomic cross section (ACS), electronic cross section (ECS), effective atomic number (Zeff), exposure build-up factor (EBF) and energy absorption build-up factor (EABF). The values were investigated in the 0.015-15 MeV range using the Phy-X/PSD software. The build-up factors were also analyzed using the geometric progression (G-P) method up to a penetration depth of 40 mean free path (MFP). Based on the results, Efavirenz and Indinavir were found to have the highest and lowest radiation reduction capacities, respectively. It is believed that these findings can be used to make medical processes more beneficial.

Keywords

Supporting Institution

No financial support has been received from any organization or person to prepare this manuscript.

Ethical Statement

1. The authors declare that there is no conflict of interest or competing interest relevant to the content of this manuscript. 2. All national and international ethical guidelines have been adhered to in the preparation of the article.

References

  1. Au, N. P. B., Wu, T., Kumar, G., Jin, Y., Li, Y. Y. T., Chan, S. L., ... & Ma, C. H. E. (2024). Low-dose ionizing radiation promotes motor recovery and brain rewiring by resolving inflammatory responses after brain injury and stroke. Brain, Behavior, and Immunity, 115, 43-63.
  2. Evans, E., & Stafford, J. (2018). Principles of cancer treatment by radiotherapy. Surgery (Oxford), 36(3), 111-116.
  3. Cuttler, J. M. (2020). Application of low doses of ionizing radiation in medical therapies. Dose-response, 18(1), 1559325819895739.
  4. Chirenje, Z. M. (2005). HIV and cancer of the cervix. Best practice & research Clinical obstetrics & gynaecology, 19(2), 269-276.
  5. Shiels, M. S., Pfeiffer, R. M., Gail, M. H., Hall, H. I., Li, J., Chaturvedi, A. K., ... & Engels, E. A. (2011). Cancer burden in the HIV-infected population in the United States. Journal of the National Cancer Institute, 103(9), 753-762.
  6. Akman, F., & Kaçal, M. R. (2018). Investigation of radiation attenuation parameters of some drugs used in Chemotherapy in the Wide Energy Region. Journal of Radiology and Oncology, 2, 047-052.
  7. Çağlar, İ., & Cengiz, G. B. (2021). Evaluation of radiation attenuation properties of some cancer drugs. Adıyaman University Journal of Science, 11(2), 503-522.
  8. Tuğrul, T. (2020). Investigation of mass attenuation coefficients, effective atomic numbers, and effective electron density for some molecules: study on chemotherapy drugs. Journal of Radiation Research and Applied Sciences, 13(1), 758-764.

Details

Primary Language

English

Subjects

Atomic and Molecular Physics, Nuclear Physics, Radiophysics, Particle and High Energy Physics (Other)

Journal Section

Research Article

Publication Date

June 27, 2025

Submission Date

January 7, 2025

Acceptance Date

May 24, 2025

Published in Issue

Year 2025 Volume: 14 Number: 2

APA
Akbaba, U., Kamacı, K., & Şakar, E. (2025). Investigation of Radiation Interaction Parameters of Anti-Human Immunodeficiency Virus Drugs in Wide Energy Region. Turkish Journal of Nature and Science, 14(2), 204-212. https://doi.org/10.46810/tdfd.1614991
AMA
1.Akbaba U, Kamacı K, Şakar E. Investigation of Radiation Interaction Parameters of Anti-Human Immunodeficiency Virus Drugs in Wide Energy Region. TJNS. 2025;14(2):204-212. doi:10.46810/tdfd.1614991
Chicago
Akbaba, Ugur, Kübra Kamacı, and Erdem Şakar. 2025. “Investigation of Radiation Interaction Parameters of Anti-Human Immunodeficiency Virus Drugs in Wide Energy Region”. Turkish Journal of Nature and Science 14 (2): 204-12. https://doi.org/10.46810/tdfd.1614991.
EndNote
Akbaba U, Kamacı K, Şakar E (June 1, 2025) Investigation of Radiation Interaction Parameters of Anti-Human Immunodeficiency Virus Drugs in Wide Energy Region. Turkish Journal of Nature and Science 14 2 204–212.
IEEE
[1]U. Akbaba, K. Kamacı, and E. Şakar, “Investigation of Radiation Interaction Parameters of Anti-Human Immunodeficiency Virus Drugs in Wide Energy Region”, TJNS, vol. 14, no. 2, pp. 204–212, June 2025, doi: 10.46810/tdfd.1614991.
ISNAD
Akbaba, Ugur - Kamacı, Kübra - Şakar, Erdem. “Investigation of Radiation Interaction Parameters of Anti-Human Immunodeficiency Virus Drugs in Wide Energy Region”. Turkish Journal of Nature and Science 14/2 (June 1, 2025): 204-212. https://doi.org/10.46810/tdfd.1614991.
JAMA
1.Akbaba U, Kamacı K, Şakar E. Investigation of Radiation Interaction Parameters of Anti-Human Immunodeficiency Virus Drugs in Wide Energy Region. TJNS. 2025;14:204–212.
MLA
Akbaba, Ugur, et al. “Investigation of Radiation Interaction Parameters of Anti-Human Immunodeficiency Virus Drugs in Wide Energy Region”. Turkish Journal of Nature and Science, vol. 14, no. 2, June 2025, pp. 204-12, doi:10.46810/tdfd.1614991.
Vancouver
1.Ugur Akbaba, Kübra Kamacı, Erdem Şakar. Investigation of Radiation Interaction Parameters of Anti-Human Immunodeficiency Virus Drugs in Wide Energy Region. TJNS. 2025 Jun. 1;14(2):204-12. doi:10.46810/tdfd.1614991